Wang Tanchun, Kendig Derek M, Smolock Elaine M, Moreland Robert S
Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Am J Physiol Renal Physiol. 2009 Dec;297(6):F1534-42. doi: 10.1152/ajprenal.00095.2009. Epub 2009 Sep 30.
Smooth muscle contraction is regulated by phosphorylation of the myosin light chain (MLC) catalyzed by MLC kinase and dephosphorylation catalyzed by MLC phosphatase. Agonist stimulation of smooth muscle results in the inhibition of MLC phosphatase activity and a net increase in MLC phosphorylation and therefore force. The two pathways believed to be primarily important for inhibition of MLC phosphatase activity are protein kinase C (PKC)-catalyzed CPI-17 phosphorylation and Rho kinase (ROCK)-catalyzed myosin phosphatase-targeting subunit (MYPT1) phosphorylation. The goal of this study was to determine the roles of PKC and ROCK and their downstream effectors in regulating MLC phosphorylation levels and force during the phasic and sustained phases of carbachol-stimulated contraction in intact bladder smooth muscle. These studies were performed in the presence and absence of the PKC inhibitor bisindolylmaleimide-1 (Bis) or the ROCK inhibitor H-1152. Phosphorylation levels of Thr(38)-CPI-17 and Thr(696)/Thr(850)-MYPT1 were measured at different times during carbachol stimulation using site-specific antibodies. Thr(38)-CPI-17 phosphorylation increased concurrently with carbachol-stimulated force generation. This increase was reduced by inhibition of PKC during the entire contraction but was only reduced by ROCK inhibition during the sustained phase of contraction. MYPT1 showed high basal phosphorylation levels at both sites; however, only Thr(850) phosphorylation increased with carbachol stimulation; the increase was abolished by the inhibition of either ROCK or PKC. Our results suggest that during agonist stimulation, PKC regulates MLC phosphatase activity through phosphorylation of CPI-17. In contrast, ROCK phosphorylates both Thr(850)-MYPT1 and CPI-17, possibly through cross talk with a PKC pathway, but is only significant during the sustained phase of contraction. Last, our results demonstrate that there is a constitutively activate pool of ROCK that phosphorylates MYPT1 in the basal state, which may account for the high resting levels of MLC phosphorylation measured in rabbit bladder smooth muscle.
平滑肌收缩受肌球蛋白轻链(MLC)磷酸化调节,MLC磷酸化由MLC激酶催化,去磷酸化由MLC磷酸酶催化。激动剂刺激平滑肌会导致MLC磷酸酶活性受到抑制,MLC磷酸化净增加,进而使张力增加。据信,对MLC磷酸酶活性抑制起主要作用的两条途径是蛋白激酶C(PKC)催化的CPI - 17磷酸化和Rho激酶(ROCK)催化的肌球蛋白磷酸酶靶向亚基(MYPT1)磷酸化。本研究的目的是确定PKC和ROCK及其下游效应器在调节完整膀胱平滑肌中卡巴胆碱刺激收缩的相性和持续性阶段MLC磷酸化水平及张力方面的作用。这些研究在存在和不存在PKC抑制剂双吲哚马来酰亚胺 - 1(Bis)或ROCK抑制剂H - 1152的情况下进行。使用位点特异性抗体在卡巴胆碱刺激的不同时间测量Thr(38)-CPI - 17和Thr(696)/Thr(850)-MYPT1的磷酸化水平。Thr(38)-CPI - 17磷酸化与卡巴胆碱刺激产生的张力同时增加。在整个收缩过程中,PKC抑制可降低这种增加,但仅在收缩的持续阶段ROCK抑制才会降低这种增加。MYPT1在两个位点均显示出高基础磷酸化水平;然而,仅Thr(850)磷酸化随卡巴胆碱刺激而增加;ROCK或PKC抑制均可消除这种增加。我们的结果表明,在激动剂刺激期间,PKC通过CPI - 17的磷酸化调节MLC磷酸酶活性。相反,ROCK使Thr(850)-MYPT1和CPI - 17均磷酸化,可能是通过与PKC途径的相互作用,但仅在收缩的持续阶段才显著。最后,我们的结果表明,存在一个组成性激活的ROCK池,其在基础状态下使MYPT1磷酸化,这可能解释了在兔膀胱平滑肌中测得的MLC磷酸化的高静息水平。